ToddMichaelBauerMD

Clinical Trials

• Study of INC280 in Patients With c-MET Dependent Advanced Solid Tumors Start of enrollment: 2012 Feb 29

  Completed

  Phase 1

• First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Mirvetuximab Soravtansine in Adults With Ovarian Cancer and Other Folate Receptor 1 (FOLR1)-Positive Solid Tumors Start of enrollment: 2012 Jun 28

  Completed

  Phase 1

• A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of KTN3379 in Adult Subjects With Advanced Tumors Start of enrollment: 2014 Jan 01

  Completed

  Phase 1

• Study of CLR457 Administered Orally in Adult Patients With Advanced Solid Malignancies Start of enrollment: 2014 Aug 07

  Terminated

  Phase 1

• Study of Intravenous RXDX-107 in Patients With Solid Tumors Start of enrollment: 2015 Sep 01

  Terminated

  Phase 1

• Study of Rovalpituzumab Tesirine (SC16LD6.5) for Third-Line and Later Treatment of Subjects With Relapsed or Refractory Delta-Like Protein 3-Expressing Small Cell Lung Cancer Start of enrollment: 2016 Jan 25

  Completed

  Phase 2

• A Study of LY3022855 in Combination With Durvalumab or Tremelimumab in Participants With Advanced Solid Tumors Start of enrollment: 2016 Jun 16

  Completed

  Phase 1

• This Study Aims to Find the Best Dose of BI 907828 (Brigimadlin) in Patients With Different Types of Advanced Cancer (Solid Tumors) Start of enrollment: 2018 May 21

  Recruiting

  Phase 1

• Join now to see all